Latest Insider Transactions at Infinity Pharmaceuticals, Inc. (INFI)
This section provides a real-time view of insider transactions for Infinity Pharmaceuticals, Inc. (INFI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INFINITY PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INFINITY PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2023
|
Adelene Q Perkins Director |
SELL
Open market or private sale
|
Direct |
410,196
-25.87%
|
$0
$0.07 P/Share
|
|
Sep 09
2023
|
Adelene Q Perkins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
768,133
+32.64%
|
-
|
|
Aug 02
2022
|
Stephane Peluso Chief Scientific Officer |
BUY
Open market or private sale
|
Direct |
14,994
+28.81%
|
$0
$0.66 P/Share
|
|
Aug 02
2022
|
Stephane Peluso Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.0%
|
-
|
|
Jun 16
2022
|
Brian Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
30,919
+50.0%
|
$0
$0.68 P/Share
|
|
Jun 16
2022
|
Anthony B Evnin |
BUY
Grant, award, or other acquisition
|
Direct |
46,378
+17.72%
|
$0
$0.68 P/Share
|
|
Jun 10
2021
|
Anthony B Evnin |
BUY
Grant, award, or other acquisition
|
Direct |
3,061
+1.78%
|
$9,183
$3.43 P/Share
|
|
Jun 10
2021
|
David W Beier |
BUY
Grant, award, or other acquisition
|
Direct |
3,061
+25.86%
|
$9,183
$3.43 P/Share
|
|
May 14
2021
|
Norman C Selby |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.0%
|
$0
$0.92 P/Share
|
|
Feb 11
2021
|
Bvf Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,260,085
-21.67%
|
$11,300,425
$5.37 P/Share
|
|
Jan 22
2021
|
Bvf Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,848,520
-38.53%
|
$23,394,080
$4.14 P/Share
|
|
Dec 13
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
175,000
+1.21%
|
$175,000
$1.2 P/Share
|
|
Nov 28
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+1.51%
|
$100,000
$1.3 P/Share
|
|
Nov 21
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,700
+0.05%
|
$4,700
$1.35 P/Share
|
|
Nov 19
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,465,126
+3.97%
|
$1,465,126
$1.36 P/Share
|
|
Nov 15
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
91,474
+0.67%
|
$91,474
$1.35 P/Share
|
|
Nov 14
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
210,250
+1.55%
|
$210,250
$1.34 P/Share
|
|
Nov 13
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
604,208
+4.78%
|
$604,208
$1.35 P/Share
|
|
Jun 21
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
425,531
+3.02%
|
$425,531
$1.65 P/Share
|
|
Jun 19
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,516,560
+19.0%
|
$3,516,560
$1.65 P/Share
|
|
Apr 10
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,010,000
+9.34%
|
$2,020,000
$2.0 P/Share
|
|
Apr 09
2018
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
500,000
+5.86%
|
$500,000
$1.9 P/Share
|
|
Oct 04
2017
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
653,449
+7.34%
|
$653,449
$1.28 P/Share
|
|
Oct 03
2017
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
946,597
+9.21%
|
$946,597
$1.24 P/Share
|